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ABSTRACT
Objective: To compare the levels of 25-hydroxyvitamin D in patients with AIS and a control group. Methods: The patients were recruited 
from the outpatient clinic of our institution during the year of 2013. Children diagnosed with scoliosis before 10 or after 18 years of age, and 
those suffering from neurological or muscular disorders, congenital malformations or genetic syndromes were excluded. The 25-OHD levels 
were determined by a fully automated electrochemiluminescence  test. The appropriate level of 25-OHD was defined as greater than 30 ng/
mL. The results were compared to a group of healthy individuals. Results: In group 1 (control) 63,3% showed abnormal vitamin D levels, 
while 91% of patients with AIS presented a low level of vitamin D. The mean BMI was 19.6 kg/m2 for controls and 20.3 kg/m2 for group 2. 
Statistical analysis showed significant difference (p<0.0001) between the levels of vitamin D. The average and minimum levels of vitamin 
D were respectively 27 and 13.6 ng/mL for group 1 and 18.8 and 3.13 ng/mL for AIS group. Conclusions: Patients with AIS had statistically 
significant lower levels of 25-OHD than healthy patients. Further research should be conducted to investigate the actual impact of serum 
vitamin D levels on the pathophysiology of AIS.
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RESUMO
Objetivo: Comparar os níveis de 25-hidroxivitamina D em pacientes com EIA e um grupo controle. Métodos: Os pacientes foram 
recrutados no ambulatório de nossa instituição durante 2013. Crianças com escoliose diagnosticada antes de 10 ou após 18 
anos de idade, portadoras de distúrbios neurológicos ou musculares, deformidades congênitas ou síndromes genéticas foram 
excluídas. Os níveis de 25-OHD foram determinados por teste de eletroquimioluminescência totalmente automatizado. O nível 
adequado de 25-OHD foi definido como acima de 30 ng/ml. Os resultados foram comparados a um grupo de indivíduos saudáveis. 
Resultados: No grupo 1 (controle), 63,3 % apresentaram níveis anormais de vitamina D, enquanto 91% dos pacientes portadores 
de EIA apresentaram baixo nível de vitamina D. A média do IMC foi de 19,6 kg/m2 para os controles e 20,3 kg/m2 no grupo 2. A 
análise estatística demonstrou diferença relevante (p < 0,0001) entre os níveis de vitamina D. A média e os valores mínimos de 
vitamina D foram respectivamente 27 e 13,6 ng/ml para o grupo 1 e 18,8 e 3,13 ng/ml para o grupo EIA. Conclusões: Pacientes 
portadores de EIA tinham níveis de 25-OHD mais baixos do que os pacientes saudáveis, com significância estatística. O presente 
estudo sugere que a deficiência da vitamina D possa estar relacionada com a etiologia da escoliose idiopática do adolescente, 
corroborando dados da literatura. Mais pesquisas devem ser desenvolvidas para investigar o impacto real dos níveis séricos de 
vitamina D sobre a fisiopatologia da EIA.
Descritores: Vitamina D; Deficiência de vitaminas; Escoliose/etiologia; Doenças da coluna vertebral.
RESUMEN
Objetivo: Comparar los niveles de 25-hidroxivitamina D en pacientes con EIA y un grupo control. Métodos: Los pacientes fueron reclutados 
en el ambulatorio de nuestra institución durante el año de 2013. Se excluyeron los niños diagnosticados con escoliosis antes de 10 años o 
después de 18 años, y quienes sufren de trastornos neurológicos o musculares, malformaciones congénitas o síndromes genéticos. Los 
niveles de 25-OHD se determinaron mediante un ensayo de electroquimiolumniscencia totalmente automatizado. El nivel apropiado de 
25-OHD se define como mayor que 30 ng/ml. Los resultados se compararon con un grupo de individuos sanos. Resultados: En el grupo 
1 (control), 63,3% tenían niveles anormales de vitamina D, mientras que el 91% de los pacientes con EIA mostraron bajo nivel de vitamina 
D. El IMC promedio fue 19,6 Kg./m2 para los controles y 20,3 Kg./m2 para el grupo 2. El análisis estadístico mostró diferencias significativas 
(p < 0,0001) entre los niveles de vitamina D. Los valores medios y  mínimos de vitamina D fueron respectivamente 27 y 13,6 ng/ml para el 
grupo 1 y 18,8 y 3,13 ng/ml para el grupo EIA. Conclusiones: Los pacientes con EIA tenían niveles más bajos de 25-OHD que los pacien-
tes sanos, con significación estadística. Este estudio sugiere que la deficiencia de vitamina D puede estar relacionada con la etiología de 
la escoliosis idiopática del adolescente, lo que confirma los datos publicados. Más investigación debe llevarse a cabo para investigar el 
impacto real de la concentración de vitamina D en la fisiopatología de la EIA.
Descriptores: Vitamina D; Avitaminosis; Escoliosis/etiología; Enfermedades de la columna vertebral.
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Idiopathic scoliosis is the most frequently diagnosed spinal de-
formity, affecting 2% to 4% of children.1 It is a three-dimensional 
deformity, with alterations in the frontal, sagittal and axial planes, in 
the absence of congenital malformations, neuromuscular diseases, 
metabolic disorders or genetic syndromes.
The cause is still unknown, and there is no theory that explains 
all the aspects of this deformity. It is accepted that its etiology is 
probably multifactorial,1,2 resulting from a combination of genetic and 
environmental factors. Structural alterations of the vertebral and para-
vertebral tissues, and neuromuscular, proprioceptive, hormonal and 
biomechanical factors may be involved in the genesis of this disease, 
and there is also a clear association with age, sex and growth.1,2
The genetic heritage of scoliosis probably involves multiple genes 
and genetic polymorphisms.1 It is known that female patients with 
idiopathic scoliosis tend to be taller and thinner, and there is evidence 
of abnormal growth patterns.1
Scoliosis can occur through de novo mutation, but it is common 
to find more than one individual affected in the same family. The 
incidence is higher among first-degree relatives, and the inheritance 
pattern remains undefined.2
Skeletal maturity, potential remaining growth and age at menar-
che are classic risk factors for curve progression.3 Recent evidence 
suggests that osteopenia may also be a risk factor for progression.1,4
Some studies suggest an association between the development 
of adolescent idiopathic scoliosis (AIS) and polymorphisms of the 
vitamin D receptor (VDR) gene, a molecule that is crucial for main-
taining adequate bone density.4-7
Vitamin D has been extensively studied in recent years, and the 
importance of this structure has been found to surpass the muscu-
loskeletal benefits,4,8,9 acting in more than 30 organs and 200 genes10 
and exercising influence on the cardiovascular apparatus and the 
immune system.4,8 It is also associated with a reduced risk of certain 
neoplastic diseases, such as colon, breast and prostate cancer.10
It appears in the form of D2 (ergocalciferol) in plants and D3
(cholecalciferol) in animals. The estimated required daily intake of vita-
min D is around 4000 IU.10-12 Ninety percent originates from the cuta-
neous production of this molecule, under the action of ultraviolet (UV) 
radiation, which justifies lower levels of 25-hydroxyvitamin D (calcidiol), 
a metabolite that is generally administered at higher latitudes and in 
late winter. The remainder, around 400 UI, must be ingested mainly 
from oily fish (tuna, sardines, salmon), eggs and fortified foods.10,12,13
Vitamin D, whether produced in the skin or absorbed, is hydroxyl-
ated in the hepatic tissue to 25-OH-vitamin D (calcidiol), and once 
again hydroxylated in the kidneys under the influence of parathyroid 
hormone (PTH) to 1alpha,25-dihydroxyvitamin D (calcitriol), which 
is the metabolically active form.10,13 (Figure 1) The second hydrox-
ylation can also occur in inflammatory processes in the peripheral 
tissues, through the action of cytokines. Calcitriol is an important 
regulator of calcium homeostasis, and is necessary for the mainte-
nance of muscle strength.1,10,11,13
The level of vitamin D is considered normal if above 30 ng/mL, 
insufficient between 20 and 30, and deficient if below 20 ng/mL, 
according to the American Society of Endocrinology.1,10,12,13
This study assesses the association of serum vitamin D levels 
(25-hydroxyvitamin D) with the occurrence of adolescent idio-
pathic scoliosis.
METHODS
The project was duly submitted to the Plataforma Brasil elec-
tronic system (062600/2013) and approved by the Research Ethics 
Committee of our institution, under number CEP 211236.
The cases were selected from the Spinal Outpatient Clinic of the 
institution in the first half of 2013, recruiting patients with scoliosis 
diagnosed between 10 and 18 years of age, regardless of their 
ethnicity or sex. Patients with congenital deformities, neuromuscular 
diseases and genetic syndromes were excluded from the study 
group, as were any patients with metabolic disorders related to 
calcium and phosphorus homeostasis, thyroid or parathyroid endo-
crinopathies, absorption disorders and nephropathies. The enrolled 
patients (Group 1) read and signed the Informed Consent Form.
The control group (Group 2) was composed of normal indi-
viduals taken from the database of the institution’s Rheumatology 
Discipline. It does not include individuals with rheumatic diseases, 
or patients on chronic medication.
Fifty-eight patients with scoliosis were initially selected. Two were 
excluded as they had been diagnosed before the age of ten years, and 
one as this patient presented signs suggestive of cerebral palsy. Thus 
55 patients formed group 1. Group 2 was comprised of 60 patients.
The patients in group 1 were aged 12-47 years (20 ± 7.7), while 
those in group 2 were between four and 19 years (13.6 ± 3.4). Most 
of the patients were female, 93% in group 1 and 80% in group 2. In 
group 1, 43.64% of the patients were White, 53% of mixed race and 
0.36% Black. In group 2, 58.3% of the patients were White, 36.7% 
of mixed race and 5% Black.
In group 2, all the patients had a BMI of 20-25 kg/m2, and were 
considered eutrophic. In group 1 there were 72.7% eutrophic pa-
tients, 12.7% had below-normal BMI (< P5), and 14.5% had elevated 
BMI (> P85), criteria adopted by the Center for Disease Control and 
Prevention (CDC). (Figure 2) 
Peripheral blood was drawn from cases and controls in early 
spring, late September and early October, a time of the year when 
we find the lowest levels of 25-OH-vitamin D. After fasting for 8 hours, 
30 mL samples were taken from each patient then immediately 
centrifuged and frozen for storage until all the material was available 
for processing.
Total calcium (colorimetric method), phosphorus (colorimetric 
method), urea (UV kinetic method), creatinine (colorimetric kinetic) 
and parathyroid hormone (PTH) (electrochemiluminometric method) 
levels were determined to rule out impaired kidney function and sec-
ondary hyperparathyroidism. Levels of 25-hydroxyvitamin D (25OHD) 
were determined using the commercial kit Elecsys® Vitamin D Total, 
fully automated electrochemiluminescence immunoassay (Roche). 
Levels below 30 ng/mL were considered insufficient and below 20 
ng/mL deficient.
Besides the blood samples, anthropometric data such as stature 
and weight were measured in cases and controls, to calculate the 
body mass index (BMI).
The data obtained were submitted to the D’Agostino-Pearson 
normality test. The comparison relative to the categorical variables 










was made using Spearman’s test, while Pearson’s test was applied 
to the numerical variables. To compare vitamin D levels between 
cases and controls, the data were submitted to the Student’s t-test. 
The significance level was 5% for all the tests.
RESULTS
Creatinine, calcium, phosphorus and parathyroid hormone levels 
of the cases and controls were within normal limits. (Table 1)
In group 1, 34 patients (62%) had 25OHD levels below 20 ng/mL, 
16 (29%) below 30 ng/mL and five (9%) patients presented normal 
levels, above 30 ng/mL. The minimum value for this group was 
3.13, the maximum 39.77, and the mean 18.83 (± 7.9). In group 2, 
the levels ranged between 13.58 and 41.73, mean 27.05 (± 7.12). 
Eleven patients (18.3%) had levels below 20 ng/mL, 27 (45%) below 
30 ng/mL, and 22 (36.7%) presented normal levels. (Figure 3)
All the parameters evaluated were submitted to the D’Agostino-
Pearson normality test, which confirmed the normal distribution of 
the variables analyzed.
The correlation between the variables BMI and 25OHD was inves-
tigated for group 1 and between the groups. The correlation between 
the BMI and 25OHD categories within group 1 was calculated using 
Spearman’s correlation test, obtaining a correlation coefficient (r) of 
0.095 (p=0.49).
The correlation between the absolute numerical values of BMI 
and of 25OHD was performed using Person’s correlation test, and 
the correlation coefficients obtained were r=0.034 (p=0.8) for group 1
(Figure 4), and r=-0.121 (p=0.36) for group 2. (Figure 5)
The statistical analysis of the categorical variables of vitamin D 
between the two groups was performed using the Mann Whitney test 
(p<0.0001). The statistical calculations relating to the numerical data 
were performed by the unpaired t-test in three stages. Firstly, consid-
ering all the cases, we observed lower levels of vitamin D in group 
1, p<0.0001. (Figure 6) The same calculations were performed in 
the subsequent stages, excluding cases over 30 and 20 years of 
age, and the result was the same (p<0.0001).
DISCUSSION
Vitamin D acts as a hormone in the human body.8 Produced by 
the skin or ingested, it is metabolized and the end product of this 
pathway acts in various systems and performs vital roles in main-
taining the structure and function of the musculoskeletal tissues.4,10 
Recent evidence suggests a material impact of vitamin D on bone 
mineral density and on the development of deformities, such as 
adolescent idiopathic scoliosis.4-7
Figure 2. Number of cases by BMI category in the patients with AIS.
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Figure 5. BMI x Vitamin D correlation in group 2.


















Figure 4. BMI x Vitamin D correlation in group 1.























































Table 1. Description of the results of C, Ca, P and PTH for cases and controls.
Minimum Maximum Mean SD
1 2 1 2 1 2 1 2
Creatinine (mg/dL) 0.36 0.5 1.03 1.2 0.63 0.77 0.12 0.16
Calcium (mg/dL) 7.6 9 11.6 11 9.1 9.98 0.62 0.52
Phosphorus (mg/dL) 2.7 2.7 5.2 6.3 3.93 4.23 0.57 0.77
Parathyroid
hormone (pg/mL)
15 11.37 57.2 76.38 33.75 30.65 10.3 14.93
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Demographic analysis of the groups shows that they are well 
paired for the variables sex and ethnicity. As regards the variable 
age, the possible impact of the extreme values found in group 1 
(eight patients over 30 years of age), was minimized by the calcu-
lations of vitamin D level comparison excluding patients ≥ 30 years, 
and then excluding patients ≥ 20 years of age. Moreover, we can 
consider that age was not a preponderant factor in the definition 
of 25OHD levels, a variable more closely related to other factors 
discussed below.
The body mass index appeared normal in all the patients in 
group 2. In group 1 we found seven patients with BMI below normal 
for their age, and considered the finding compatible with the char-
acteristic biotype of AIS patients.14 The two patients with elevated 
BMI above 30 kg/m2 among the cases were over 30 years of age, 
and calculations were performed disregarding them. No correlation 
was noted between the variations in the body mass index among 
the cases and vitamin D levels, demonstrating a weak influence of 
BMI on serum 25OHD levels.
The normal results of calcium, phosphorus, creatinine, and 
parathyroid hormone allowed us to rule out the existence of renal 
and metabolic disorders that could interfere in the metabolic path-
ways of 25OHD.
Comparison of vitamin D levels between the two groups, both 
as categorical and numerical variables, showed significant differ-
ence according to the Mann Whitney test and the t-test. There is 
a considerable difference between the means (18.83 in group 1; 
27.05 in group 2). This result suggests a factor possibly involved 
in the pathophysiology of adolescent idiopathic scoliosis. Studies 
show the importance of vitamin D in the maintenance of bone and 
muscle homeostasis,1,10,11,15 and changes in the quality of these 
tissues may create an environment favorable to loss of alignment 
and the installation of deformities.1,4-6
We know that several factors influence vitamin D levels. Varia-
tions that can occur due to dietary habits, level of physical activity 
and amount of exposure to the sun were not covered in this study.4,10 
Ninety percent of the recommended daily vitamin D intake is deter-
mined by cutaneous production under ultraviolet radiation.10,13 Both 
groups were made up of children and adolescents with the same 
potential for sun exposure, as they are all from the same region, at 
the same latitude, and were studied at the same time of the year: 
early spring in Brazil, when vitamin D levels are lower due to limited 
exposure in the previous season.10,13
We must also consider that individuals with skeletal deformities 
are more insecure about their own bodies, a fact that may prevent 
them from exposing their bodies to the sun or engaging in physical 
and recreational activities like other children.
Group 1 contains some late postoperative individuals, patients 
in the adult phase operated more than 10 years ago. The possible 
impact of these extremes on our outcome was eliminated by ex-
cluding the older patients from the final analysis. The results show 
that when we eliminated patients over 20 years of age, we obtained 
the same result and the same degree of association (p < 0.0001).
Evidence in the literature of the impact of a deficiency of the 
hormone studied on the musculoskeletal tissues1,9 confirms our 
hypothesis, and indicates a direction for studying the etiology of 
adolescent idiopathic scoliosis. Future surveys should be conducted 
to confirm the importance of 25OHD in the pathophysiology of AIS.
CONCLUSION
Patients with adolescent idiopathic scoliosis included in this 
survey have lower serum vitamin D levels in comparison to patients 
without spinal deformity. In both the cases and the controls, there 
was no association between body mass index and serum 25OHD 
levels. This study suggests that vitamin D deficiency may be related 
to the etiology of adolescent idiopathic scoliosis, corroborating data 
from the literature. However, many variables are involved in the 
regulation of 25OHD levels that were not covered in this preliminary 
study, and further studies are needed, to establish the true impact 
of this hormone on the development of spinal deformities.
All authors declare no potential conflict of interest concerning 
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Figure 6. Vitamin D in groups 1 and 2.
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